MedPath

Digoxin

These highlights do not include all the information needed to use DIGOXIN TABLETS safely and effectively. See full prescribing information for DIGOXIN TABLETS. DIGOXIN tablets, for oral use Initial U.S. Approval: 1954

Approved
Approval ID

dfac7f13-28be-423d-9389-9089da29da17

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 1, 2019

Manufacturers
FDA

Amneal Pharmaceuticals of New York LLC

DUNS: 123797875

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

DIGOXIN

PRODUCT DETAILS

NDC Product Code0115-9822
Application NumberANDA078556
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJune 1, 2019
Generic NameDIGOXIN

INGREDIENTS (5)

DIGOXINActive
Quantity: 250 ug in 1 1
Code: 73K4184T59
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

DIGOXIN

PRODUCT DETAILS

NDC Product Code0115-9811
Application NumberANDA078556
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJune 1, 2019
Generic NameDIGOXIN

INGREDIENTS (6)

DIGOXINActive
Quantity: 125 ug in 1 1
Code: 73K4184T59
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
FD&C YELLOW NO. 5Inactive
Code: I753WB2F1M
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Digoxin - FDA Approval | MedPath